News | May 27, 2022
DFE Pharma opens its new Center of Excellence in Hyderabad, India
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Abevmy follows the launch of the company’s two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in the country – and Fulphila (bPegfilgrastim), which was launched in 2020
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
In clinical trials, treatment proved more effective than other therapies evaluated
The partners also aim to expand their work to Latin America for the first time
Subscribe To Our Newsletter & Stay Updated
